Moreover, TIA was shown to intercept the PI3K/Akt and STAT3 pathways in pancreatic cancer cells [44,45], diminish ERK1/2 activity in lung cancer cells [46], and activate the ATM/Chk2 and p38 MAPK pathways in breast cancer [47]. This evidence concerns the gene AKT1 and lung cancer.